KOCITAF TABLET 30'S

KOCITAF TABLET 30'S is not a cure for HIV. It is an antiretroviral medication that helps control the virus, reduce its replication, and slow down the progression of the disease. It is essential to continue taking the medication as prescribed, even if you feel well, to maintain viral suppression and protect your immune system.

KOCITAF TABLET 30'S may affect some individuals' cholesterol and blood sugar levels. Regular monitoring of these parameters is recommended, especially in individuals with pre-existing conditions such as diabetes or high cholesterol. Lifestyle modifications or additional treatments may be considered if necessary.

Abruptly stopping KOCITAF TABLET 30'S without medical guidance can lead to viral rebound and a decrease in treatment effectiveness. It is important to consult with your healthcare provider before changing your HIV treatment regimen.

People with liver disease, including chronic hepatitis B or C taking antiretrovirals have a higher risk of severe and potentially fatal liver complications. If you have hepatitis B infection, your doctor will carefully consider the best treatment regimen for you.

KOCITAF TABLET 30'S is approved for use in children and adolescents above a certain age and body weight. The appropriate dosage and safety considerations for pediatric populations should be discussed with a pediatric HIV specialist.

KOCITAF TABLET 30'S may interact with other medications. It is important to inform your healthcare provider about all the medicines, supplements, and herbal products you are currently taking to avoid potential interactions.

If you are living with HIV or are at risk, seek medical advice and follow the prescribed plan. Consistently take KOCITAF TABLET 30'S as directed and attend follow-ups. Practice safe sex, use clean needles, and take preventive measures to reduce transmission risk. Never share needles or items with blood/body fluids. Consult healthcare professionals for personalized advice.

KOCITAF TABLET 30'S contains DOLUTEGRAVIR, EMTRICITABINE, and TENOFOVIR ALAFENAMIDE as active ingredients.

KOCITAF TABLET 30'S is an antiviral medication primarily used for the treatment of HIV/AIDS.

Kocitaf Tablet 30's contains Dolutegravir 50 MG + Emtricitabine 200 MG + Tenofovir Alafenamide 25 MG.

Kocitaf Tablet 30's is listed at Rs. 3150 on Medkart. Prices can change — check the product page for the current price and pack size.

The dose of Kocitaf Tablet 30's depends on your condition, age, weight and other medicines you take, so it must be decided by your doctor. Follow the dose and duration on your prescription and do not change it on your own.

A generic medicine is one with the same active composition as the branded product — for Kocitaf Tablet 30's that is Dolutegravir 50 MG + Emtricitabine 200 MG + Tenofovir Alafenamide 25 MG. Medkart lists generic options by composition so you can compare. Ask your doctor or pharmacist before switching from Kocitaf Tablet 30's.

Yes. Kocitaf Tablet 30's requires a valid doctor's prescription.

Kocitaf Tablet 30's is manufactured by Mylan Pharmaceuticals Private Limited.

Kocitaf Tablet 30's is supplied as a tablet and is taken by the oral route.

Whether Kocitaf Tablet 30's can be taken daily, and for how long, depends on your condition and must be decided by your doctor. Do not start, extend or repeat a course of Kocitaf Tablet 30's on your own.

The timing of Kocitaf Tablet 30's depends on the dose your doctor prescribes and on the other medicines you take. Follow the timing on your prescription or ask your pharmacist.

No. Kocitaf Tablet 30's is a prescription medicine and should only be taken on a doctor's advice.

Store Kocitaf Tablet 30's in its original pack, below 25°C unless the pack states otherwise, away from direct sunlight and moisture, and out of the reach of children. Do not use it after the expiry date on the pack.